Airway proteins involved in bacterial clearance susceptible to cathepsin G proteolysis.
Serine proteases released from neutrophils are central to the pathogenesis of cystic fibrosis lung disease and are considered to be obvious therapeutic targets. Neutrophil elastase digests key opsonins present in the lung and disrupts phagocytosis, allowing bacteria to persist despite established pulmonary inflammation. We have found that cathepsin G, an abundant serine protease found in human and murine neutrophils, has other roles in the development of suppurative lung diseases. Murine models of endobronchial inflammation indicate that cathepsin G inhibits airway defences and interferes with the host's ability to clear Pseudomonas aeruginosa from the lung with effects distinct from neutrophil elastase. We hypothesise that differences in bacterial killing are due to defects in innate defences created by proteolysis. Protein profiles of bronchoalveolar lavage of infected wild-type and cathepsin G-deficient mice were compared using two-dimensional polyacrylamide gel electrophoresis and tandem mass spectrometry. Four proteins in bronchoalveolar lavage were cleaved by cathepsin G. Serum amyloid P component leaked into the lung during acute infection and was digested by cathepsin G. Its cleavage products had greater binding to lipopolysaccharide and interfered with phagocytosis. These results indicate that cleaved serum amyloid P component acts as an anti-opsonin and interferes with bacterial clearance from the lung.
Farberman
M M
MM
Division of Paediatric Allergy and Pulmonary Medicine, Dept of Paediatrics, Washington University School of Medicine, 660 South Euclid Avenue, Mailbox 8116, St Louis, MO 63110, USA.
Akers
K T
KT
Malone
J P
JP
Erdman-Gilmore
P
P
Townsend
R R
RR
Ferkol
T
T
D000818:Animals; D001980:Bronchi / Q000382:microbiology; D018893:Bronchoalveolar Lavage; D056649:Cathepsin G / Q000737:chemistry* / Q000378:metabolism; D015180:Electrophoresis, Gel, Two-Dimensional / Q000379:methods; D018922:HL-60 Cells; D006801:Humans; D008168:Lung / Q000382:microbiology / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D009504:Neutrophils / Q000378:metabolism; D009895:Opsonin Proteins / Q000737:chemistry; D010587:Phagocytosis; D000683:Serum Amyloid P-Component / Q000096:biosynthesis; D053719:Tandem Mass Spectrometry / Q000379:methods
D009895:Opsonin Proteins; D000683:Serum Amyloid P-Component; D056649:Cathepsin G
Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1665-70
8256917
Infect Immun. 1999 Jun;67(6):2790-6
10338482
Exp Lung Res. 2005 Nov-Dec;31(9-10):855-71
16684717
Clin Diagn Lab Immunol. 1997 Jul;4(4):415-22
9220157
Electrophoresis. 1997 Oct;18(11):2071-7
9420172
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11785-90
15280543
Eur J Biochem. 1994 Aug 1;223(3):805-11
8055957
J Biol Chem. 1995 Oct 6;270(40):23437-43
7559504
Blood. 1999 Dec 15;94(12):4282-93
10590073
Am J Respir Crit Care Med. 2000 Jan;161(1):271-9
10619831
Am J Respir Crit Care Med. 1994 Aug;150(2):448-54
8049828
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14584-9
11121061
Mol Cell Proteomics. 2002 Feb;1(2):117-24
12096129
Proteomics. 2001 Mar;1(3):377-96
11680884
J Leukoc Biol. 2001 Feb;69(2):197-206
11272269
Pediatr Res. 2007 Jan;61(1):26-31
17211136
Proteomics. 2006 Jul;6(14):4084-99
16791827
Am J Med. 1988 Jun 24;84(6A):37-42
2454577
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 5;815(1-2):169-78
15652807
Proteomics. 2003 Jan;3(1):36-44
12548632
J Immunol. 2004 Jan 1;172(1):509-15
14688361
Infect Immun. 1976 Aug;14(2):555-63
971964
Eur Respir J. 1995 Jan;8(1):10-4
7744174
Infect Immun. 1993 May;61(5):1900-8
8478079
J Immunol. 1998 Oct 1;161(7):3607-15
9759883
Shock. 2004 Feb;21(2):144-50
14752288
Am J Respir Crit Care Med. 1994 Jul;150(1):207-13
7912987
Biochim Biophys Acta. 1980 Jan 24;621(1):147-57
6153274
Anal Chem. 2003 Mar 15;75(6):1300-6
12659189
Sarcoidosis. 1992 Mar;9(1):3-14
1344040